Results 281 to 290 of about 985,459 (298)

SUBSTITUTED PYRROLOPYRIDINES AS JAK INHIBITORS

2022
JACOBSEN ERIC JON, ANDERSON DAVID RANDOLPH, BLINN JAMES ROBERT, MUKHERJEE PARAMITA, CHANGELIAN PAUL, XU CANXIN   +5 more
openaire   +2 more sources

DIHYDROPYRROLONAPHTHYRIDINONE COMPOUNDS AS INHIBITORS OF JAK

2010
DONG QING, KANOUNI TOUFIKE, LAWSON JOHN DAVID, WALLACE MICHAEL B   +3 more
openaire   +5 more sources

Fragment-based discovery of JAK-2 inhibitors

Bioorganic and Medicinal Chemistry Letters, 2009
exaly  

JAK INHIBITORS

2019
openaire   +3 more sources

JAK INHIBITOR

2008
AMISHIRO NOBUYOSHI, ATSUMI TOSHIYUKI, NAKAZATO TOMOYUKI, UMEHARA HIROSHI, FUJIHARA HIROAKI, SHINOHARA FUMIKAZU, FUNAHASHI JUN, YAMAMOTO JUNICHIRO, YAGI KAORI   +8 more
openaire   +1 more source

TRICYCLIC INHIBITORS OF JAK

2011
openaire   +2 more sources

JAK inhibitors—Friend or Foe?

The Lancet Rheumatology
openaire   +2 more sources

Inhibitors of JAK

2013
DE VICENTE FIDALGO JAVIER, HERMANN JOHANNES CORNELIUS, LEMOINE REMY, LI HONGJU, LOVEY ALLEN JOHN, SJOGREN ERIC BRIAN, SOTH MICHAEL   +6 more
openaire   +1 more source

JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? A Systematic Review of the Published Literature

Cancers
Nima Hajizadeh, Chalid Assaf, Ifa Etesami   +2 more
exaly  

Benefits of the Topical JAK Inhibitor Delgocitinib in a Patient With Pediatric Localized Scleroderma

Pediatric Dermatology
Kozo Nakai, Kimiko Nakajima, Mayuko Yamamoto   +2 more
exaly